These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 25721095
1. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase. Vivas-Colmenares GV, Bernabeu-Wittel J, Alonso-Arroyo V, Matute de Cardenas JA, Fernandez-Pineda I. Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095 [Abstract] [Full Text] [Related]
2. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases. Tian Y, Xu DP, Tong S, Xi SL, Liu ZM, Wang XK. J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227 [Abstract] [Full Text] [Related]
3. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, Puttgen KB, Dohil M, Fischer G, Powell J, Cohen B, Ben Amitai D. Pediatr Dermatol; 2011 Aug; 28(2):94-8. PubMed ID: 21362031 [Abstract] [Full Text] [Related]
4. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. Bertrand J, Sammour R, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Boutin C, Bortoluzzi P, Laberge LC, Powell J. J Cutan Med Surg; 2012 Aug; 16(2):115-21. PubMed ID: 22513064 [Abstract] [Full Text] [Related]
5. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. Bertrand J, Sammour R, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Boutin C, Bortoluzzi P, Laberge LC, Powell J. J Cutan Med Surg; 2012 Aug; 16(5):317-23. PubMed ID: 22971306 [Abstract] [Full Text] [Related]
6. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases. Sagi L, Zvulunov A, Lapidoth M, Ben Amitai D. Dermatology; 2014 Aug; 228(2):136-44. PubMed ID: 24556822 [Abstract] [Full Text] [Related]
7. The use of propranolol for complicated infantile hemangiomas. Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P. Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783 [Abstract] [Full Text] [Related]
9. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol. Ahogo CK, Ezzedine K, Prey S, Colona V, Diallo A, Boralevi F, Taïeb A, Léauté-Labrèze C. Br J Dermatol; 2013 Dec; 169(6):1252-6. PubMed ID: 23662995 [Abstract] [Full Text] [Related]
10. Late rebound of infantile hemangioma after cessation of oral propranolol. Shehata N, Powell J, Dubois J, Hatami A, Rousseau E, Ondrejchak S, McCuaig C. Pediatr Dermatol; 2013 Dec; 30(5):587-91. PubMed ID: 24016283 [Abstract] [Full Text] [Related]
11. [Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants]. Yilmaz L, Dangoisse C, Semaille P. Rev Med Brux; 2015 Dec; 36(1):3-9. PubMed ID: 25856965 [Abstract] [Full Text] [Related]
12. Propranolol therapy for infantile hemangioma: our experience. Zhang L, Wu HW, Yuan W, Zheng JW. Drug Des Devel Ther; 2017 Dec; 11():1401-1408. PubMed ID: 28507428 [Abstract] [Full Text] [Related]
13. [Treatment of superficial infantile hemangiomas with topical propranolol]. Niu JN, Xu GQ, Lü RR, Huo R. Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486 [Abstract] [Full Text] [Related]
14. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T. Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809 [Abstract] [Full Text] [Related]
15. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients. Stringari G, Barbato G, Zanzucchi M, Marchesi M, Cerasoli G, Tchana B, Gritti A, Boccaletti V, Lombardi AA, Carano N. Pediatr Med Chir; 2016 Jun 27; 38(2):113. PubMed ID: 27345601 [Abstract] [Full Text] [Related]
16. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Broeks IJ, Hermans DJ, Dassel AC, van der Vleuten CJ, van Beynum IM. Int J Pediatr Otorhinolaryngol; 2013 Nov 27; 77(11):1791-800. PubMed ID: 24074695 [Abstract] [Full Text] [Related]
17. Long-term treatment with oral propranolol reduces relapses of infantile hemangiomas. Giachetti A, Garcia-Monaco R, Sojo M, Scacchi MF, Cernadas C, Guerchicoff Lemcke M, Dovasio F. Pediatr Dermatol; 2014 Nov 27; 31(1):14-20. PubMed ID: 24283619 [Abstract] [Full Text] [Related]
18. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol. Sondhi V, Patnaik SK. J Pediatr Hematol Oncol; 2013 Oct 27; 35(7):493-9. PubMed ID: 23929318 [Abstract] [Full Text] [Related]
19. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region. Sadykov RR, Podmelle F, Sadykov RA, Kasimova KR, Metellmann HR. Int J Oral Maxillofac Surg; 2013 Jul 27; 42(7):863-7. PubMed ID: 23618833 [Abstract] [Full Text] [Related]
20. Topical propranolol for treatment of superficial infantile hemangiomas. Xu G, Lv R, Zhao Z, Huo R. J Am Acad Dermatol; 2012 Dec 27; 67(6):1210-3. PubMed ID: 22516113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]